Similar Posts
Is MindMed the NEXT Tesla? (MindMed Bull Thesis)
Is MindMed (MMED / MMEDF) the next Tesla (TSLA)? It could be. In this video we give the bull case scenario for MindMed, and give a general company overview.
MindMed (MMED) is our favorite psychedelic stock by far, with trials using LSD to treat anxiety and ADHD, as well as their proprietary 18-MC compound to treat addiction.
Follow us on social media!
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestorMusic: www.bensound.com
► Music Credit: LAKEY INSPIRED
Track Name: “Blue Boi”
Music By: LAKEY INSPIRED @ https://soundcloud.com/lakeyinspiredOriginal upload HERE – https://www.youtube.com/watch?v=wAukv…
Official “LAKEY INSPIRED” YouTube Channel HERE – https://www.youtube.com/channel/UCOmy…
License for commercial use: Creative Commons Attribution 3.0 Unported “Share Alike” (CC BY-SA 3.0) License.
Full License HERE – https://creativecommons.org/licenses/…Music promoted by NCM https://goo.gl/fh3rEJ
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
Links from studies and websites :
https://www.cdc.gov/nchs/pressroom/podcasts/20190911/20190911.htm?fbclid=IwAR3_UBSk2yv4lwOld0su1YpnJHsjPA4x5XK-X2pO5LMz1AeXiojkswcDV8Y#:~:text=Anestimated69029peopledied,wereduetoheroinhttps://www.hhs.gov/opioids/about-the-epidemic/index.html?fbclid=IwAR0df0UXoVhfWf03RQNkP5OMInM5Nyxz6j68V5GXr5lv0lDUuRL_R-UL4ZA
https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/opioid-addiction?fbclid=IwAR31PQiu49359xjhzD4sTgcicRQLGh-l95y2DuFihHPdql87eHTDnYsTELw
https://preprod.drugfree.org/article/relapse-overdose/?fbclid=IwAR1YSZEIUDCiYDeBIYCk1WhEA_NJCrjyyz56zteyrbGKhDYQtsu2X1fDVOM
https://www.drugabuse.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery?fbclid=IwAR2_c4gVhURANeU5pCc0k97Ba4ML-kYZIGOZvGfqpHmo8o4jdxZp0SEHyQQ
https://maps.org/research-archive/presentations/Brown_GITA_Vancouver_Oct2012_iboga_comm_rev.pdf
https://www.tandfonline.com/doi/full/10.1080/00952990.2017.1310218?fbclid=IwAR0OBK0eFJ64-v7gu1yE1TnyUIK1XhSDJvd_XLxhZaRtC4bWF8MfD0ine3M
https://www.healio.com/news/primary-care/20191205/ibogaine-treatment-for-opioid-use-disorder-what-you-need-to-know?fbclid=IwAR39o1sonUGLHsMGwH3pzbm3aAkU98P15CFNYaQX0r3VNQtJdSy3pazvRJM#
https://mindmed.co/psychedelic-inspired/?fbclid=IwAR1EK84fYX4WrObq45LkQfkZiW3ZtUYNsVZ4Y9q_wMHqas7y8IwoJmFyTBs#scroll_section-1
https://www.globenewswire.com/news-release/2020/02/20/1988216/0/en/Drug-Addiction-Treatment-Market-To-Reach-USD-31-17-Billion-By-2027-Reports-And-Data.html?fbclid=IwAR2ZeDBuW69x1DkczkxVRmadUBTpwu1Dilur64LkqBISH1Dqu8FC3EgFzmU
https://adaa.org/about-adaa/press-room/facts-statistics?fbclid=IwAR2YlG6rTd0jdUP3XIkm0t-_-QRYDyWDlVGh_sF6CZkayVEyGUZZpGcplwE#:~:text=Anxietydisordersarethemost,ofthosesufferingreceivetreatment
https://adaa.org/finding-help/treatment/medication?fbclid=IwAR10tRsqwdRMx-PqpKA9yx5BPGvNcVJRugkw3L6tq7DrDIO4gVdNwb6BGJ4
https://www.newswire.ca/news-releases/mindmed-receives-approval-of-protocol-design-to-evaluate-microdoses-of-lsd-for-adult-adhd-in-phase-2a-clinical-trial-from-swiss-and-dutch-health-authorities-897700369.html?fbclid=IwAR0jnNn2wDJocJEkfVGMtC1idTsBdupLZw-VQ0ddJskemRH0B8d50ykq0ng
https://maps.org/research-archive/lsd/Gasser-2014-JMND-4March14.pdf
https://www.smartpatients.com/trials/NCT03153579?fbclid=IwAR0df0UXoVhfWf03RQNkP5OMInM5Nyxz6j68V5GXr5lv0lDUuRL_R-UL4ZA
https://www.marketwatch.com/press-release/global-anxiety-disorders-and-depression-treatment-market-2020-research-report-with-consumption-revenue-opportunities-market-share-and-growth-rate-covid-19-impact-and-forecast-to-2026-absolute-reports-2020-11-06?fbclid=IwAR1jEtR6h9mTPla8OzW5RiIW2ecf_HnrT7of42bU4mO5dsfpxxuCAFv-7bE
https://www.additudemag.com/statistics-of-adhd/?fbclid=IwAR1mQaSVujUayYXwzCQRryiCZzM4gckjKAbg5O9H5BwCJIUbrXypOlgU4qM#:~:text=About6.1millionchildrenin,ControlandPrevention(CDC)
https://www.additudemag.com/adhd-medication-for-adults-and-children/?fbclid=IwAR0jnNn2wDJocJEkfVGMtC1idTsBdupLZw-VQ0ddJskemRH0B8d50ykq0ng
https://www.floridarehab.com/drugs/meth/related/meth-vs-adderall/?fbclid=IwAR0WbOJtUIMcW4sPsQ7TUR-ulrPC9rwa1b2_KxHw_lFJBk_ygesCtsQJqDs
https://www.drugwatch.com/adderall/side-effects/?fbclid=IwAR3_UBSk2yv4lwOld0su1YpnJHsjPA4x5XK-X2pO5LMz1AeXiojkswcDV8Y
https://drug-dev.com/adhd-treatment-market-value-to-reach-9-9-billion/?fbclid=IwAR0jnNn2wDJocJEkfVGMtC1idTsBdupLZw-VQ0ddJskemRH0B8d50ykq0ng
https://mindmed.co/team/
#MindMed #MMED #Mindmedstock #Tesla #TSLA #PsychedelicStocks #ThePsychedelicInvestor
This Week in Psychedelic Stocks [UPDATES ON MINDMED (MMED/MMEDF) CMPS, NUMI & ATAI, CYBIN]
In today’s episode of “This Week in Psychedelic Stocks”, we’ll see some news on MindMed (MMED / MMEDF/MMQ), Compass Pathways (CMPS), Atai Life Sciences, Numinus Wellness (NUMI), Cybin.
We will cover the latest developments in the field writ large.
This means we will cover any stories that affect the all the companies in this field, as well as company specific developments.Timestamps:
0:00 – Intro
0:32 – Norway Decriminalization Bill
1:59 – Psychedelic Market Stats
3:21 – Magic Mushrooms to Treat Obesity
5:40 – Ketamine to Treat Suicidal Thoughts?
7:09 -The Acid King?
8:58 – MindMed (MMED/MMEDF/MMQ) Updates
10:04 – Compass Pathways (CMPS) Updates
11:44 – Atai Life Sciences Updates
14:02 – Numinus (NUMI) Updates
15:13 – CYBIN UpdatesSo this is it for This Week in Psychedelic Stocks fellow psychedelic investors!
I hope you guys found some value in this and I’ll keep you posted for more changes!
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestorFacebook: @thepsychedelicinvestor
Music: www.bensound.comDISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMed #MindmedStock #PsychedelicStocks
Scientists Create A New DMT: Can it Treat Depression? | Psychedelic Therapy
Scientists Create A New DMT: Can it Treat Depression? | Psychedelic Therapy
When it comes to treating mental health conditions with psychedelic therapy, one of the most promising compounds is DMT, the main ingredient in the brew ayahuasca. While DMT may have many potential advantages over other similar compounds such as psilocybin, for example, its short duration of effect, the hallucination can be very intense.
It is an open question whether the mental health benefits we see from psychedelic therapy are due to the experience one undergoes when having a hallucination, or whether it comes strictly from the drug’s effects on the brain. If it is the latter, then hypothetically speaking, we could create a version of DMT that does not cause a hallucination.
Enter Psilera Biosciences.
Psilera is a psychedelic medicines company working to create next-generation psychedelics for use in therapeutic settings. Specifically, they aim to create non-psychedelic versions of classical psychedelics such as psilocybin, LSD and DMT.
PSIL-002 is Psilera’s version of non-hallucinogenic DMT. They recently completed a pre-clinical trial in mice that showed that their version of DMT was safe and non-psychedelic. Now they have to show that their version of DMT can treat depression and addiction, starting with alcoholism.
If Psilera’s DMT can treat these mental health conditions equally as well as regular DMT, but without the intense hallucination, then PSIL-002 would probably be the better compound.
It is exciting to see Psilera’s scientists working on answering the following questions:
Can DMT treat depression?
Can psychedelics help with depression?
Can psychedelics help with Mental Health?Enjoy the episode!
Follow us on social media!
Instagram: @thepsychedelicinvestor
Facebook: @thepsychedelicinvestor
James’ Twitter: @Psy_Invest
Maria’s Twitter (Producer & Editor): @Psy_HolyWant to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.comVideo editing: @themyaholy @Psy_holy
#DMT #DEPRESSION #PSYCHEDELICTHERAPY
Changing Lives Through Psychedelic-Assisted Therapy – Healing Souls
In today’s episode, we talk with Dr. Ryan Westrum, the founder and visionary of Healing Souls, a practice dedicated to changing the way individuals, couples and families look at counseling.
How to Microdose Magic Mushrooms in 5 EASY Steps For Beginners (Plus: Does Microdosing Really Work?)
In this episode, we’re covering what is microdosing and its purported benefits. You will learn how to microdose magic mushrooms. How to microdose psychedelics.
Microdosing is the practice of taking a small dose of a drug, in our case psilocybin, the main active ingredient in magic mushrooms. The dose is small enough that it won’t cause any perceptual changes, meaning you won’t have any hallucinations or even feel high.
This will allow you to continue to go to school, work, or get more comfortable in social settings.According to thousands upon thousands of anecdotal stories over decades, microdosing psilocybin is purported to:
– Improve your creativity;
– Help you enter states of flow, also known as “being in the zone” or entering a mental state of total energized concentration;
– Help alleviate feelings of stress and anxiety;
– Improve focus and concentration;
– Improves relational awareness and;
– Speeds your reflexes.We have to rely on anecdotal evidence unfortunately, because until recently, very little scientific study has been done on the subject of microdosing, though that is starting to change with many clinical studies underway.
Despite a lack of hard scientific data, the practice is sworn upon by many in high pace environments, such as Silicon Valley. A couple famous examples of microdosers include: Joe Rogan and Steve Jobs, though for the later it was more LSD microdosing.
Let me know in the comments if you want to see a video on LSD microdosing in the future.
Enjoy the episode!Follow us on social media! 🙌
Instagram: @thepsychedelicinvestor
Facebook: @thepsychedelicinvestorWant to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.comMusic from:
www.bensound.comVideo editing: @themyaholy
Check out our Benziga discounts
https://benzinga.grsm.io/jameshallifa…
https://benzinga.grsm.io/thepsychedel…DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#MicrodosingMushrooms #Microdosing #MagicMushrooms
![This Week in Psychedelic Stocks [UPDATES ON MINDMED (MMED/MMEDF) CMPS, NUMI & ATAI, CYBIN]](https://psychedelicspotlight.com/wp-content/uploads/2022/06/maxresdefault-46-600x338.jpeg)
